In March 2024, the Food and Drug Administration (FDA) cleared Dexcom’s Stelo ... Using a continuous glucose monitor involves sticking a disposable sensor to the body, commonly on the back ...

Dexcom CEO Kevin Sayer shared new data on the company’s first over-the-counter glucose sensor at the J.P. Morgan Healthcare Conference on Monday. Stelo, which is indicated for people who don’t ...

When blood glucose information is received by a smart device, it is transmitted via the cloud to up to five selected followers, such as parents, caregivers, and medical providers. This information can ...

The company added that details of the settlement are confidential. In March 2024, a jury found that Dexcom’s G6 glucose monitors infringed one of three of Abbott’s patents, but jurors couldn’t reach a ...

if a person with diabetes used the company’s G7 sensor and app to share their glucose data with healthcare providers or family members. Dexcom had taken Abbott to court in the EU in early 2024 ...

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A better-than-expected third-quarter 2024 performance and a series of favorable coverage ...

Non-invasive blood glucose measurement is one of the so-called ... which means that it could be incorporated alongside the existing optical sensors in devices like the Galaxy Watch or potentially ...